TrialPloS one2015

Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial.

Jiska B Snoeck-Stroband et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.